Childhood Cancer Awareness Month

Send a message of support to patients battling cancer at Nationwide Children's!

Our cancer team at Nationwide Children’s is committed to treating the whole patient through their entire cancer journey and beyond. This September, we’re showing just how much happens during that journey for pediatric cancer patients. From research, to diagnosis, to long term care, we’ll be sharing stories and resources you can use to better understand pediatric cancer and make a difference in a patient’s life.

We hope you will join us to honor children and families who have fought cancer in the past, support those who are currently in the midst of their fight, and work towards more solutions for the almost 300,000 children who will be diagnosed with cancer around the world in the next year.

Diagnosis and Treatment 

Making the Most of 4%

Pediatric cancer research receives just 4% of the federally-funded annual budget from the National Cancer Institute (NCI). Much of this is do the high cure rate of pediatric cancers when compared to cancers in other populations. While the cure rate for pediatric cancer may be comparatively high, the childhood cancer community still relies on support beyond this 4% to provide the necessary research and clinical trials for patients of the rarest cancer diagnoses.

We’ve come a long way with the 4% of funds allocated by the NCI; but we still have a long way to go to provide the future each child effected by pediatric cancer deserves. Imagine what we could do with your help.

"The field has proven that research cures cancer. So we can’t rest until we cure everyone."-Dr. Timothy Cripe MD, PhD, Chief of the Division of Hematology, Oncology and Blood and Marrow Transplant 

Research: from Bench to Bedside

Childhood Cancer Awareness Month Research Graphic

Helping Patients on a Global Scale

At Nationwide Children’s, we’re on the cutting edge of solutions for pediatric cancer patients worldwide. Our Hematology, Oncology and Blood and Marrow Transplant teams are leading collaborations to investigate innovative treatments for cancer.

 Clinical Trial Statistics

 

Treatment

The NEXT Consortium

Dr. Finley

The NEXT Consortium is a collaborative research model that unites multiple research centers with the goal of expediting the most advanced treatments in the shortest timeframe possible in pediatric cancers.

Learn More

Immunotherapy

Immunotherapy

Nationwide Children’s is a leader in virotherapy research, including participating in the first clinical trial of virotherapy in pediatric cancers.

Learn More

Good Manufacturing Practice

Good Manufacturing Practice Facility

Nationwide Children’s is one of the first pediatric institutions in the country to build a Good Manufacturing Practice facility designed to research the rarest pediatric cancers. The space ensures the highest level of product safety and purity to support more accurate early phase clinical trials.

Learn More

MIBG

MIBG, called meta-iodobenzylguanidine, is a chemical that is usually picked up by neural crest cells. Neural crest cells can give rise to a type of cancer called neuroblastoma. Neuroblastomas are in a class of tumors (called neuro-endocrine tumors) that will take up MIBG and can respond to treatment with MIBG. The high-dose radioactive form of MIBG (called I-131 MIBG ) is used for treatment. I-131 MIBG is a very effective medication when used to treat neuroblastoma that has responded well to traditional treatments. Roughly 80-85% of neuroblastomas will absorb MIBG.

Since we aren’t the only ones doing this, what makes us special?

We treat the whole family– period. We don’t forget that the patient beneath the sheets is still a young child. Children receiving therapy with I-131 MIBG must remain in a special room for 3 to 5 days. As such these kids and their families have very special and very unique needs. Our team of physicians, nurses, psychologists, social workers, child life specialists, music therapists, radiation safety specialists, and administrators are experts at tailoring your child’s and family’s treatment experience to meet your unique needs.


Support

Psychosocial Services

When your child is sick, it can be hard to understand what is happening, to make decisions and to juggle family responsibilities. Our Psychosocial Services Team will treat the whole child by assist them in coping with their new cancer diagnosis, minimizing stress and fears about medical procedures and treatments such as chemotherapy and radiation or surgery, and help siblings understand what is happening to their brother or sister.

Learn more about Psychosocial Services >>

Cancer Genetics Clinic

Our multidisciplinary team has developed an approach to provide a personalized screening and treatment that helps identify children who may have a condition or family history that increases their chance of receiving a cancer diagnosis.

Learn more about our cancer genetics clinic >>

Going Gold to Crush Cancer

Going Gold for Cancer Lights
Showing support: Light sticks in front of the main hospital are gold to raise awareness for Childhood Cancer Awareness month.

Longer Term Care

Survivorship Clinics

Survivorship Clinics Patient

Our survivorship Clinics strive to improve the quality of all aspects of life – medical, emotional, educational, and social of the children as they grow into adulthood. Learn more about our clinics.

Learn More

Inside Survivorship Clinic with Dr. Randal Olshefski

Dr. Randal Olshefski Patient

Cancer survivorship is a journey that doesn’t end after treatment. The effects of the disease and treatments can be felt for decades. Dr. Randal Olshefski team team makes sure childhood cancer survivors at Nationwide Children’s have specialized care that is tailored to their survivorship needs.

Watch Here

Battle on Baby Boy!

Nathan

Meet Nathan, a three-year-old both with LiFraumeni Syndrome. Now over one year strong from his diagnosis, learn more about his journey to recovery.

Read More